Lene Margrethe Ring Madsen

Massiv akut overdosering med liraglutid medførte ikke hypoglykæmi

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Standard

Massiv akut overdosering med liraglutid medførte ikke hypoglykæmi. / Madsen, Lene Margrethe Ring; Christiansen, Jens Juel.

I: Ugeskrift for Laeger, Bind 177, Nr. 5, 26.01.2015, s. V11140595.

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Harvard

Madsen, LMR & Christiansen, JJ 2015, 'Massiv akut overdosering med liraglutid medførte ikke hypoglykæmi', Ugeskrift for Laeger, bind 177, nr. 5, s. V11140595.

APA

Madsen, L. M. R., & Christiansen, J. J. (2015). Massiv akut overdosering med liraglutid medførte ikke hypoglykæmi. Ugeskrift for Laeger, 177(5), V11140595.

CBE

Madsen LMR, Christiansen JJ. 2015. Massiv akut overdosering med liraglutid medførte ikke hypoglykæmi. Ugeskrift for Laeger. 177(5):V11140595.

MLA

Madsen, Lene Margrethe Ring og Jens Juel Christiansen. "Massiv akut overdosering med liraglutid medførte ikke hypoglykæmi". Ugeskrift for Laeger. 2015, 177(5). V11140595.

Vancouver

Madsen LMR, Christiansen JJ. Massiv akut overdosering med liraglutid medførte ikke hypoglykæmi. Ugeskrift for Laeger. 2015 jan 26;177(5):V11140595.

Author

Madsen, Lene Margrethe Ring ; Christiansen, Jens Juel. / Massiv akut overdosering med liraglutid medførte ikke hypoglykæmi. I: Ugeskrift for Laeger. 2015 ; Bind 177, Nr. 5. s. V11140595.

Bibtex

@article{3b2b95f862574d88bb92b5b449514a29,
title = "Massiv akut overdosering med liraglutid medf{\o}rte ikke hypoglyk{\ae}mi",
abstract = "Glucagon-like peptide (GLP)-1 analogues such as liraglutide have gained popularity in the treatment of type 2 diabetes over the last years. By mimicking the effects of the native GLP-1, it enhances the glucose-dependent secretion of insulin, suppresses elevated glucagon secretion, increases satiety and slows down gastric emptying. Because of its ways of action it is not likely to cause hypoglycaemia in cases of overdosage. We present a 45-fold overdose of liraglutide (confirmed by P-liraglutide measurements) leading to nausea and vomiting, but no hypoglycaemia and no sign of pancreatitis.",
author = "Madsen, {Lene Margrethe Ring} and Christiansen, {Jens Juel}",
year = "2015",
month = jan,
day = "26",
language = "Dansk",
volume = "177",
pages = "V11140595",
journal = "Ugeskrift for L{\ae}ger",
issn = "0041-5782",
publisher = "Den Almindelige Danske L{\ae}geforening",
number = "5",

}

RIS

TY - JOUR

T1 - Massiv akut overdosering med liraglutid medførte ikke hypoglykæmi

AU - Madsen, Lene Margrethe Ring

AU - Christiansen, Jens Juel

PY - 2015/1/26

Y1 - 2015/1/26

N2 - Glucagon-like peptide (GLP)-1 analogues such as liraglutide have gained popularity in the treatment of type 2 diabetes over the last years. By mimicking the effects of the native GLP-1, it enhances the glucose-dependent secretion of insulin, suppresses elevated glucagon secretion, increases satiety and slows down gastric emptying. Because of its ways of action it is not likely to cause hypoglycaemia in cases of overdosage. We present a 45-fold overdose of liraglutide (confirmed by P-liraglutide measurements) leading to nausea and vomiting, but no hypoglycaemia and no sign of pancreatitis.

AB - Glucagon-like peptide (GLP)-1 analogues such as liraglutide have gained popularity in the treatment of type 2 diabetes over the last years. By mimicking the effects of the native GLP-1, it enhances the glucose-dependent secretion of insulin, suppresses elevated glucagon secretion, increases satiety and slows down gastric emptying. Because of its ways of action it is not likely to cause hypoglycaemia in cases of overdosage. We present a 45-fold overdose of liraglutide (confirmed by P-liraglutide measurements) leading to nausea and vomiting, but no hypoglycaemia and no sign of pancreatitis.

M3 - Tidsskriftartikel

C2 - 25650514

VL - 177

SP - V11140595

JO - Ugeskrift for Læger

JF - Ugeskrift for Læger

SN - 0041-5782

IS - 5

ER -